Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CNS Pharmaceuticals Inc. (CNSP) Message Board

Policies Encouraging High-Volume Facilities Disadv

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 375
(Total Views: 187)
Posted On: 09/05/2023 4:47:14 PM
Avatar
Posted By: NetworkNewsWire
Policies Encouraging High-Volume Facilities Disadvantage Oncology Patients in Rural Areas

A new analysis published in the “JCO Oncology Practice” journal has revealed that policies encouraging high-volume medical facilities may be harming cancer patients living in rural areas. Health policy researchers at the University of Pittsburg School of Public Health discovered that cancer patients in rural Pennsylvania counties seem to be choosing to go to lower-volume health facilities closer to their homes even when they know higher-volume facilities may provide better outcomes.

Rural areas often suffer from shortages of critical skills as most skilled professionals opt to move to urban areas for better pay. Rural America has a major shortage of experienced surgeons as rural areas struggle to attract and retain medical professionals over the long term. These shortages are even more acutely felt by rural cancer patients thanks to policies and programs designed to centralize cancer treatment services, especially surgical treatment, in high-volume medical facilities in mostly urban regions.

Such policies could lead to the association of insurance reimbursements with metrics that include the volume of surgeries, potentially disadvantaging cancer patients in rural areas who opt to visit facilities that have lower surgical volumes but are closer to home.

Senior study author and Pitt Public Health’s Department of Health Policy and Management associate professor Lindsay Sabik, PhD, said that the research team’s findings indicate that narrowing the focus to hospital surgical volumes and making insurance reimbursements based on volumes could mask the “complexities and trade-offs” with the potential of improving patient experiences and outcomes.

Sabik and her colleagues collected statewide data on adult patients with cancer who had surgery from 2017 to 2020 from the Pennsylvania Health Care Cost Containment Council. They found that rural cancer patients with cancers that required less-complex surgeries tended to visit local hospitals rather than high-volume facilities even though such facilities are known to produce better outcomes. Policies that prize high-volume facilities also increase overall costs for rural patients through extra travel and board expenses.

Furthermore, traveling tens or even hundreds of miles for quality treatment usually pulls rural patients away from their family, friends and support networks at a time when they need support the most. In the largely rural city of Elko, for instance, a large portion of physicians comprise medical students doing their residencies, meaning patients in such regions are often unsure of how long their physicians will stay before being forced to move on. Even though some experts say increasing the number of rural medical residency programs is key to filling critical shortages, more than 95% of U.S. residencies currently take place in urban areas.

In the coming years, the R&D programs being undertaken by entities such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) could avail brain cancer drugs that are available on the mass market and benefit not only patients in urban areas but also those in rural areas.

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer



(0)
(0)




CNS Pharmaceuticals Inc. (CNSP) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us